Company Overview and News


Add XRAY
to your dashboard

Headline News

Align Technology-Glidewell Dental Deal to Boost iTero Uptake

11h zacks
Align Technology, Inc. (ALGN - Free Report) recently signed an agreement with Glidewell Dental to distribute the iTero Element intraoral scanning system with the latest glidewell.io In-Office Solution in North America. (29-0)

Your Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets 2 FDA Approvals, GW Pharmaceuticals' Price Target Lowered

2017-11-15 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (1487-9)

Your Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets Two FDA Approvals, GW Pharmaceuticals' Price Target Lowered

2017-11-15 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (1487-2)

Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q3 2017 Update

2017-11-14 seekingalpha
Ruane, Cunniff, & Goldfarb’s 13F portfolio value increased ~6%, from $10.81B to $11.42B. The number of positions decreased from 70 to 69. (386-3)

Earnings Review and Free Research Report: C.R. Bard’s Revenue Grew 5%; Adjusted EPS Increased 14.3%

2017-11-13 accesswire
LONDON, UK / ACCESSWIRE / November 13, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on C.R. Bard, Inc. (NYSE: BCR), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=BCR, following the Company's posting of its financial results on October 25, 2017, for the third quarter fiscal 2017. The medical device manufacturer's revenue and earnings beat estimates. (52-0)

What Align Technology’s Analysts Are Thinking Now

2017-11-10 marketrealist
In 3Q17, Align Technology (ALGN) reported total revenues close to $385.3 million, which represents YoY (year-over-year) growth of ~38.3% and QoQ (quarter-over-quarter) growth of ~8.1%. This growth was driven by the rapid uptake of Invisalign cases across geographies and rising demand for iTero scanners. (27-0)

Dentsply Sirona (XRAY) a Sell on Falling Industry Group Rank

2017-11-08 investorplace
Portfolio Grader currently ranks Dentsply Sirona Inc (NASDAQ:XRAY) a Sell. The methodology for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking XRAY has had from Portfolio Grader for 2 months.

Henry Schein (HSIC) Q3 2017 Results - Earnings Call Transcript

2017-11-06 seekingalpha
Good morning, ladies and gentlemen, and welcome to the Henry Schein Third Quarter Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this call is being recorded. (5-0)

Your Daily Pharma Scoop: Progenics Looks Promising, Big Week For Dynavax, Keryx Ahead Of Catalyst

2017-11-06 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (692-4)

Stock Market News For Nov 6, 2017

2017-11-06 zacks
Benchmarks ended in the green on Friday on the back of strong earnings performance from Apple. Better-than-expected earnings results and favorable quarterly outlook from the tech giant led all the three key U.S. indexes to new record highs despite mixed jobs data. Additionally, the ISM services index hit its best level in more than twelve years, which in turn boosted the broader markets. (276-0)

Can DENTSPLY (XRAY) Deliver a Beat This Earnings Season?

2017-11-02 zacks
DENTSPLY SIRONA Inc.’s (XRAY - Free Report) third-quarter 2017 results, scheduled for release on Nov 3, are expected to show lackluster performance by dental consumables and laboratories — one of the major revenue-generating components. While this could majorly impact third-quarter earnings, an expected improvement in revenues at other segments should help the company post solid numbers. (8-1)

Henry Schein (HSIC) Q3 Earnings to Show Growth in All Lines

2017-10-23 zacks
Henry Schein, Inc. (HSIC - Free Report) is expected to report third-quarter 2017 results on Nov 1. (90-0)

Editors' Picks Daily - October 12, 2017

2017-10-12 seekingalpha
Articles get tagged with an Editors’ Pick award when they appeal to a broad audience and demonstrate convincing analysis and a clear actionable takeaway. (216-0)

DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay

2017-10-12 zacks
On Oct 11, we issued an updated research report on New York-based DENTSPLY SIRONA Inc. (XRAY - Free Report) — a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products. (40-0)

Dental Consumables Market in China 2017-2021

2017-10-10 prnewswire
NEW YORK, Oct. 10, 2017 /PRNewswire/ -- About Dental Consumables Dental consumables are products or materials that are used to carry out tooth restoration and treat dental impairments and associated gingival tissues and structures. Dental consumables are used in almost all the branches of dentistry. Dental consumables include dental sundries and small equipment that are used to treat patients. Dental sundries include dental anesthetics, dental sealants, prophylaxis paste, impression materials, restorative materials, teeth whiteners, orthodontic appliances, and topical fluoride.

CUSIP: 249030107